lsmgroup
Blog
Angel Investor

How to Contact Angel Investors: A Founder's Guide

How to contact angel investors: build a target list, use warm introductions, pitch well and stay within Rule 506(b).

By Yenvy Truong · Founder and Managing Member, The LSM Group

how to get angel investors

Key Takeaways

  • Knowing how to contact angel investors starts before the first message: a clear round size, a defined instrument and a short list of investors who actually back companies at your stage and in your sector.
  • Warm introductions from people the investor already trusts remain the most reliable route. Cold outreach can work, but only when it is short, specific and clearly tailored to the investor.
  • Most early-stage rounds rely on Rule 506(b), which prohibits general solicitation. Posting publicly about a raise or mass-emailing strangers can put the exemption at risk, while introductions through existing relationships, angel networks and qualifying demo days are generally treated differently.
  • When you approach angel investors, ask for a conversation rather than money. The first meeting is for building understanding. The commitment usually comes after diligence.
  • Healthcare, AI and life sciences founders should expect questions about clinical evidence, regulatory pathway and reimbursement, and benefit from investors with domain expertise in those areas.

For most founders, the hardest part of an angel round is not the pitch itself. It is getting in front of the right people in the first place, in a way that is credible, efficient and compliant with securities law. The LSM Group works with founders in healthcare, applied AI and life sciences, and the question of how to reach the right investors comes up in almost every first conversation.

This guide covers the full sequence: preparing before outreach, building a target list, using introductions and direct outreach, working with angel groups and syndicates, pitching, and moving from a first meeting to a closed round. It also explains the securities rules that shape how founders are allowed to contact investors. This is educational content, not legal advice, and founders should work with securities counsel before starting a raise.

Before You Reach Out: Know What You Are Raising

how to contact angel investors

Angel investors see far more companies than they can back, and they respond best to founders who can answer basic questions about the round immediately. Before working out how to contact angel investors in practice, it helps to have clear answers to the following:

  • How much you are raising, and why that amount. Tie the figure to specific milestones the capital will fund, such as a product launch, a clinical study, a regulatory submission or a first group of paying customers.
  • The instrument. Whether the round is a SAFE, a convertible note or a priced equity round affects what investors receive and when. Understanding how angel investing works from the investor's side, including dilution and pro rata rights, makes these conversations much easier.
  • Key terms. For a SAFE or note, the valuation cap and any discount. For a priced round, the pre-money valuation and the main investor rights.
  • Who is already committed. A lead investor or early commitments from credible angels make every later conversation easier.
  • Your materials. A short pitch deck, a one-paragraph company summary that can be forwarded, and, for later stages of diligence, an organized data room.

Founders who reach out before these points are settled often spend their first meetings defining the round rather than discussing the company, which slows everything down.

How to Get Angel Investors: Build a Targeted List

The answer to how to get angel investors is rarely more outreach. It is better-targeted outreach. A short list of well-matched investors usually produces more meetings than a long list of generic names.

What Makes an Investor a Good Fit

  • Sector. Angels invest most confidently in areas they understand. A cardiologist, a former medical device executive or a health system leader will evaluate a clinical product very differently from a generalist technology investor.
  • Stage. Some angels only invest before revenue, while others prefer companies with early traction. Check what stage their recent investments were at when they first invested.
  • Typical involvement. Some angels are passive, and others expect to advise closely. Both can be valuable, but the expectation should match what the company needs.
  • Conflicts. An investor who has backed a direct competitor may decline, or may not be the right person to see confidential information.

Where to Find Them

  • Your existing network. Former colleagues, advisers, customers, clinicians you have worked with and other founders. These are also the people most likely to make introductions.
  • Angel groups. Organized groups of accredited investors that screen and review companies together, often on a regular schedule. Many accept applications from founders. The trade-offs between local and national angel networks matter, particularly for founders in specialized sectors.
  • Syndicates. A lead investor reviews companies and brings opportunities to a group of investors who participate through a pooled vehicle. One relationship with a lead can give a company access to many investors.
  • Sector-focused networks. Investor networks built around healthcare, life sciences or a professional community, such as physicians, can bring both capital and expertise.
  • Accelerators, incubators and university programmes. Many run investor events and maintain relationships with active angels.

Founders who come from clinical practice often already know potential investors through their professional network. The path from clinical insight to a startup frequently runs through colleagues who later become a company's first backers.

How to Contact Angel Investors Without Breaking Securities Rules

Most angel rounds in the US are private placements under Rule 506(b), which prohibits general solicitation and general advertising. That rule has a direct effect on how founders can contact investors.

  • Public posts can be a problem. Announcing on social media or a public website that the company is raising and inviting investors to get in touch can be treated as general solicitation. Even a single public post can put a Rule 506(b) exemption at risk.
  • Existing relationships matter. The SEC has long recognized that there is no general solicitation where the company, or someone acting on its behalf, has a pre-existing, substantive relationship with the prospective investor. The relationship needs to exist before the offering begins and be substantive enough for the company to understand the investor's background and sophistication.
  • Angel networks are recognized. SEC staff guidance indicates that investors contacted through angel investor networks or similar informal networks of experienced investors can fall outside general solicitation, which is one reason introductions through these networks are so widely used.
  • Demo days have a specific safe harbor. Rule 148 provides that presentations at certain events with more than one company are not general solicitation. The event must be sponsored by a college or university, a state or local government, a nonprofit, or an angel investor group, incubator or accelerator. The presenting company may share only limited information about the offering: that it is raising, the type and amount of securities, the intended use of proceeds and the amount still unsubscribed. For online events, attendance must be limited to people associated with the sponsor, people the sponsor reasonably believes are accredited, or people invited based on relevant experience.
  • Rule 506(c) is the alternative. Under Rule 506(c), a company may advertise its offering publicly, but every purchaser must be accredited and the company must take reasonable steps to verify that status. Some companies choose this route deliberately, but it is a decision to make with counsel before any public communication, not after.

The practical lesson is to keep fundraising outreach personal and targeted. Founders should talk to counsel before announcing a raise in any public forum, including podcasts, newsletters and conference talks.

Warm Introductions: The Most Reliable Route

A warm introduction comes from someone the investor knows and trusts: another founder they have backed, a co-investor, an adviser, a lawyer or an executive they respect. It works because the investor starts the conversation with a reason to take the company seriously.

How to Ask for a Warm Introduction

  • Choose the introducer carefully. The strongest introductions come from people who know both the founder and the investor well, and who can speak credibly about the company.
  • Make it easy. Send the introducer a short, forwardable email: two or three sentences on what the company does, the current traction, what is being raised and why this particular investor is a good fit.
  • Use a double opt-in. Ask the introducer to check with the investor before connecting the two of you. Investors appreciate the courtesy, and it means the founder only enters conversations with someone who has already agreed to listen.
  • Follow up quickly. Once an introduction is made, respond within a day, thank the introducer and suggest specific times to talk.

A warm introduction does not ensure investment, but it significantly improves the chance of a first meeting. Founders who build relationships with potential investors before a raise, by sharing occasional updates or asking for advice, tend to find warm introductions much easier to arrange when the time comes.

How to Approach Angel Investors Directly

When there is no realistic route to a warm introduction, direct outreach to an investor with whom the founder has a genuine connection, or through a channel the investor has opened for applications, can still work. The key is precision. Those who know how to approach angel investors well treat each message as a short, individual note, not a campaign.

A strong direct message usually includes:

  • A specific reason for writing to this investor. A relevant prior investment, their clinical or operating background, or a mutual connection.
  • One sentence on what the company does. In plain language, without jargon.
  • Evidence of progress. Customers, pilot sites, clinical results, regulatory milestones or a notable team member.
  • The ask. A short call to share more, not a request for money.

Keep the message brief, ideally readable in under a minute. If there is no reply, one polite follow-up after a couple of weeks, ideally with a genuine update such as a new pilot or hire, is reasonable. Repeated messages rarely help.

Given the general solicitation rules above, founders should avoid sending identical messages to large lists of investors they have no relationship with. Applying through an angel group's founder application, or reaching investors through a syndicate lead, is often a more effective and more compliant form of direct outreach.

Healthcare · AI · Life Sciences

Access to Healthcare's Best De-Risked Deal Flow

Every deal is validated by domain experts before capital moves. See how the syndication model works.

Contact Us

Working With Angel Groups and Syndicates

Angel groups and syndicates have structured processes, and understanding them helps founders set realistic expectations. For many founders, an application to a well-matched group is the most practical answer to how to contact angel investors at scale while staying within private offering rules.

  1. Application. The founder submits a short application, usually with a deck and a summary of the round.
  2. Screening. A committee or lead investor reviews the application, and a small share of companies move forward.
  3. Presentation. Selected founders present to members, often in a short pitch followed by questions.
  4. Due diligence. Interested members, sometimes organized into a diligence team, review the company in more depth.
  5. Investment decision. Members decide individually, or through the syndicate's vehicle, whether to invest.

The process takes time, and the timeline varies from group to group. Founders should ask at the outset how the process works, what the typical timeline is and what information will be required at each stage.

For companies in healthcare, AI and life sciences, a group with domain expertise can add value well beyond capital. Specialist reviewers often identify regulatory, clinical or reimbursement questions that later-stage investors will ask, giving the founder time to address them early.

How to Pitch to Angel Investors

Learning how to pitch to angel investors is largely about clarity. Angels are evaluating the founder as much as the company, and they want to understand quickly what problem is being solved, why this team, and what the capital will achieve.

What the Pitch Should Cover

  • Problem and customer. Who has the problem, how they handle it today and why that is not good enough.
  • Solution. What the product does and how it fits into the customer's workflow.
  • Evidence. Traction, pilot results, clinical data, letters of intent or other proof that the solution works and is wanted.
  • Market. A realistic view of who pays and how large that opportunity is.
  • Team. Why these founders are the right people, including relevant clinical, technical or commercial experience.
  • Business model. How the company makes money and what drives its costs.
  • The round. How much is being raised, on what terms and which milestones it funds.

What Healthcare and Life Sciences Investors Ask

  • What is the regulatory pathway, and what will it cost in time and money.
  • Who pays for the product, and is there an existing reimbursement route.
  • What clinical evidence exists today, and what evidence will be needed.
  • How the product fits into existing clinical workflows and purchasing decisions.

Founders who need help preparing for these questions, or shaping milestones and positioning before a raise, can benefit from structured startup advisory support from people who have worked through the same issues.

After the First Meeting: Diligence and Closing

A positive first meeting is the start of a process, not the end of it.

  • Diligence. Investors may ask for financial statements, the cap table, customer references, technical or clinical detail, and key contracts. An organized data room speeds this up considerably.
  • Terms. For a SAFE or note, the terms are often standard. For a priced round, a lead investor usually proposes a term sheet that other investors follow.
  • Documents. Investors sign the investment documents and a subscription agreement, and confirm their accredited investor status, usually through a questionnaire.
  • Filing. In a Rule 506 offering, the company files a notice on Form D with the SEC within 15 days after the first sale, along with any state notice filings that apply.
  • Investor updates. After closing, regular, honest updates keep investors engaged and make them more likely to help with introductions for the next round.

Common Mistakes Founders Make

Many of the mistakes founders make when working out how to get angel investors are avoidable:

  • Posting about the raise publicly. A well-intentioned social media post can create a general solicitation problem under Rule 506(b).
  • Mass emailing investors. Generic messages to long lists produce few meetings and can raise compliance concerns.
  • Asking for money in the first message. The first goal is a conversation.
  • Ignoring fit. Pitching investors who do not invest in the sector or stage wastes time on both sides.
  • Starting too late. Building investor relationships takes months. Founders who start only when they need cash often raise on weaker terms.
  • Not knowing the terms. Founders should be able to explain their own SAFE, note or term sheet clearly and confidently.

Next Steps

For founders, knowing how to get an angel investor comes down to preparation, fit and relationships, and every approach should stay within the securities rules that govern private offerings. The LSM Group works with founders in healthcare, applied AI and life sciences. A specialist in the company's sector reviews it, and the process includes milestone mapping, positioning for later rounds and introductions to follow-on investors.

Founders can submit their company through a short application describing the business and what it needs, whether that is capital, advisory support or both. For questions before applying, email hello@thelsmgroup.com.

Frequently asked questions

How Do I Contact Angel Investors for the First Time?

Start with your existing network and ask for warm introductions to investors who back companies in your sector and at your stage. Send the introducer a short, forwardable summary of the company and the round. Where no introduction is possible, apply through an angel group or syndicate, or send a brief, tailored note to an investor with whom you have a genuine connection.

How to Get an Angel Investor Without an Existing Network?

Build relationships before the raise. Join accelerator or university programmes, attend sector events, apply to angel groups that accept founder applications and ask advisers, customers and other founders for introductions. Relationships formed early, before an offering begins, are also important for staying within private offering rules.

Can I Post About My Fundraise on Social Media?

If the round relies on Rule 506(b), a public post inviting investors to participate can be treated as general solicitation and put the exemption at risk. Rule 506(c) allows public advertising but requires every investor to be accredited and verified. Founders should speak with securities counsel before mentioning a raise publicly.

What Is the Best Way to Approach Angel Investors at Events?

Focus on starting a conversation and learning what the investor looks for, rather than pitching immediately. Follow up afterwards with a short, personal note. At a demo day that qualifies under Rule 148, presenting companies can share only limited information about the offering.

What Should I Include When I Pitch to Angel Investors?

Cover the problem and customer, the solution, evidence of progress, the market, the team, the business model and the details of the round, including how much is being raised and which milestones it will fund. Healthcare founders should also be ready to discuss regulatory pathway, reimbursement and clinical evidence.

How Long Does It Take to Raise From Angel Investors?

It varies widely depending on the company, the round and the investors involved. Building relationships and arranging introductions often takes months, and angel group processes add their own screening and diligence steps. Starting conversations well before the capital is needed gives founders more control over timing and terms.